Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.43 |
| ▸ | BTN3A1 | O00481 | 3/20 | 0.39 |
| ▸ | PGD | P52209 | 3/20 | 0.36 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7104415 | 0.97 | MPI (0.46) | MPIBTN3A1PGDLPAR1LPAR3 | |
| SCHEMBL15688978 | 0.86 | MPI (0.40) | MPIBTN3A1PGD | |
| SCHEMBL31282490 | 0.83 | MPI (0.34) | MPIBTN3A1 | |
| SCHEMBL31282048 | 0.83 | MPI (0.34) | MPIBTN3A1 | |
| SCHEMBL4594608 | 0.82 | MPI (0.62) | MPIPGD | |
| SCHEMBL20857032 | 0.82 | MPI (0.62) | MPIPGD | |
| SCHEMBL139868 | 0.82 | MPI (0.62) | MPIPGD | |
| Triphosphate SCHEMBL3698178 | 0.81 | MPI (0.35) | MPIBTN3A1 | |
| Triphosphate SCHEMBL27494952 | 0.81 | MPI (0.35) | MPIBTN3A1 | |
| SCHEMBL3745928 | 0.81 | PGD (0.39) | MPIBTN3A1PGDLPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118271968-A | Chemical mechanical polishing solution | 安集微电子科技（上海）股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118147284-A | Method and kit for fluorescence detection of ochratoxin | 合肥工业大学 | 2024-06-07 | — | — | CN | claimed |
| EP-4225941-A1 | IMPROVEMENTS TO REACTIONS WITH NON-RETROVIRAL REVERSE TRANSCRIPTASE | The Regents of the University of California (US) | 2023-08-16 | — | — | EP | claimed |
| CN-116515398-A | Chemical mechanical polishing solution and application method thereof | 安集微电子（上海）有限公司 | 2023-08-01 | — | — | CN | claimed |
| US-20230235302-A1 | Reactions with non-retroviral reverse transcriptase | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-07-27 | — | — | US | claimed |
| CN-113846159-B | Special chip for detecting expression of breast cancer related gene | 北京百奥纳芯生物科技有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-114907272-A | Bivalent nucleobase compound and use thereof | 卡耐基梅隆大学 | 2022-08-16 | — | — | CN | claimed |
| CN-114716915-A | Chemical mechanical polishing solution | 安集微电子科技（上海）股份有限公司 | 2022-07-08 | — | — | CN | claimed |
| EP-4731762-A2 | DE NOVO STEPWISE TEMPLATE-INDEPENDENT SYNTHESIS OF LONG POLYNUCLEOTIDES | Ansa Biotechnologies, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-3727435-B1 | BIVALENT NUCLEIC ACID LIGANDS AND USES THEREFOR | UNIV CARNEGIE MELLON (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12480106-B2 | Reactions with non-retroviral reverse transcriptase | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-11-25 | — | — | US | disclosed |
| US-12338496-B2 | Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging | Life Technologies Corporation (US) | 2025-06-24 | — | — | US | disclosed |
| US-12297231-B2 | Shape-responsive nanostructures | CARNEGIE MELLON UNIVERSITY (US) | 2025-05-13 | — | — | US | disclosed |
| WO-2025034963-A9 | CHOLESTEROL-OLIGONUCLEOTIDE TETHERS WITH APTAMERS FOR LIGAND DISPLAY AND EXTRACELLULAR VESICLE FUNCTIONALIZATION | CARNEGIE MELLON UNIVERSITY (US) | 2025-04-10 | — | — | WO | disclosed |
| WO-2006101911-A1 | SELECTIVE INHIBITORS OF TRANSLESION DNA REPLICATION | CASE WESTERN RESERVE UNIVERSITY (US) | 2006-09-28 | — | — | WO | disclosed |
| US-20020127561-A1 | Detecting preferential nucleotide sequeces in sample; obtain a sample of nucleotide sequences, incubate with probes, expose to light, monitor scattered light | Life Technologies Corporation | 2002-09-12 | — | — | US | disclosed |
| WO-2001096604-A2 | ASSAY FOR GENETIC POLYMORPHISMS USING SCATTERED LIGHT DETECTABLE LABELS | GENICON SCIENCES CORPORATION (US) | 2001-12-20 | — | — | WO | disclosed |
| WO-2000028084-A1 | ISOTHERMAL NUCLEIC ACID AMPLIFICATION METHODS | MOLECULAR BIOLOGY RESOURCES, INC. (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-1993021311-A1 | IMMORTALISATION OF HUMAN CELLS BY GENE SILENCING | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1993-10-28 | — | — | WO | disclosed |
| US-5004809-A | Nitroxide labeled nucleotides and nitroxide labeled hybridization probes | UNIVERSITY OF CINCINNATI (US) | 1991-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12297231-B2 | Shape-responsive nanostructures | SSTR1, SSTR4, SSTR3 | MPI 1027/4885BTN3A1 208/4885PGD 3066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.